Tianjing Biotechnology and Sanofi have reached an authorization agreement with a potential total price of up to 200 million euros
紫气东送
发表于 2024-9-25 20:31:38
1167
0
0
According to AI News, on September 25th, Tianjing Biotechnology announced that it has reached a strategic cooperation with Sanofi for the development, production, and commercialization of its independently developed global innovative CD73 antibody, Yulelimab, in Greater China. Sanofi will make a down payment of approximately 32 million euros and recent milestone payments to Tianjing Biotechnology, as well as specific registration and sales milestone payments; The maximum potential total consideration shall not exceed 213 million euros.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Stellantis Group's net profit for the first half of the year was 5.65 billion euros, a year-on-year decrease of 48%
- Trillion giants suddenly face negative news! Uber fined 290 million euros by Dutch regulatory authorities
- Shanghai CDC says flu vaccine reserves are sufficient, industry estimates Sanofi's suspension of vaccination will result in losses of at least hundreds of millions of euros
- Boeing reaches agreement with largest union to avoid strike
- Apple and Google lost the lawsuit! Apple will pay 13 billion euros in taxes
- Guoyin Jinzhu: Signed an aircraft purchase agreement with Boeing to purchase 50 737-8 aircraft
- Google wins EU advertising antitrust case, court withdraws 1.49 billion euros fine
- OPEC+reportedly strengthens supervision and vows to reshape the authority of the production reduction agreement
- ASML's net sales for the third quarter were 7.5 billion euros, but new orders were lower than expected, putting pressure on the stock price
- Nokia and Chunghwa Telecom reach extension agreement on 5G Advanced
-
"영비릉: 2024회계연도 영업수입 동기대비 8% 감소"영비릉은 2024회계연도 재무제보를 발표했다.2024 회계연도 매출은 149억5500만 유로로 전년 동기 대비 8% 감소했습니다.이익은 31억 500만 유로입니다.이익률은 ...- 勇敢的树袋熊1
- 3 일전
- Up
- Down
- Reply
- Favorite
-
계면신문기자 장우발 4분기의 영업수입이 하락한후 텐센트음악은 다시 성장으로 돌아왔다. 11월 12일, 텐센트음악은 최신 재보를 발표했다.2024년 9월 30일까지 이 회사의 3분기 총수입은 70억 2천만 위안으로 전년 ...
- 勇敢的树袋熊1
- 그저께 15:27
- Up
- Down
- Reply
- Favorite
-
본사소식 (기자 원전새): 11월 14일, 다다그룹 (나스닥코드: DADA) 은 2024년 3분기 실적보고를 발표했다. 수치가 보여준데 따르면 고품질발전전략에 지속적으로 전념하고 사용자체험을 끊임없이 최적화하며 공급을 ...- 家养宠物繁殖
- 어제 15:21
- Up
- Down
- Reply
- Favorite
-
11월 12일 소식에 따르면 소식통에 따르면 아마존은 무료스트리밍서비스 Freevee를 페쇄하고 일부 종업원과 프로를 구독서비스 Prime Video로 이전할 계획이다. 올해 초 아마존이 내놓은 몇 편의 대형 드라마의 효 ...- 度素告
- 그저께 13:58
- Up
- Down
- Reply
- Favorite
